**Core Concept**
Chronic hepatitis B is a liver infection caused by the hepatitis B virus (HBV), leading to inflammation and potentially severe liver damage. The disease is characterized by a complex interaction between the virus and the host immune system, involving various cellular and molecular mechanisms.

**Why the Correct Answer is Right**
Active chronic hepatitis B is typically associated with high levels of HBV DNA, elevated liver enzymes (such as ALT and AST), and the presence of HBV antigens in the blood. The disease can be divided into two phases: the immune tolerant phase and the immune active phase. In the immune active phase, the host immune system mounts an aggressive response against the virus, leading to liver inflammation and damage. This phase is often characterized by the presence of HBV surface antigen (HBsAg) and the presence of antibodies against HBV core antigen (anti-HBc).

**Why Each Wrong Option is Incorrect**
**Option A:** HBV surface antibody (anti-HBs) is typically associated with immunity to hepatitis B, either through vaccination or past infection, and is not a marker of active chronic hepatitis B.
**Option B:** HBV e-antigen (HBeAg) is a marker of viral replication and active hepatitis B infection, and its presence is often associated with a high viral load and liver inflammation.
**Option C:** HBV DNA polymerase inhibitor resistance is a concern in patients with chronic hepatitis B, particularly those who have received antiviral therapy, and is associated with ongoing viral replication and liver damage.

**Clinical Pearl / High-Yield Fact**
In patients with chronic hepatitis B, the presence of HBV surface antigen (HBsAg) for more than 6 months is a marker of chronic infection, and regular monitoring of liver enzymes and HBV DNA levels is essential to assess disease activity and monitor the effectiveness of antiviral therapy.

**Correct Answer: A. HBV surface antibody (anti-HBs)**